ArticleOncotarget2015

Sorafenib and DE605, a novel c-Met inhibitor, synergistically suppress hepatocellular carcinoma.

Xiufeng Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.